Insider · CIK 0001597334

PASQUALONE FRANK

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001597334

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ENVBEnveric Biosciences, Inc.A Award	Director	AAward	+18.5K sh	—	—	26,423
2025-12-23	ENVBEnveric Biosciences, Inc.A Award	Director	AAward	+7,633 sh	—	—	7,904
2024-10-09	ENVBEnveric Biosciences, Inc.A Award	Director	AAward	+47.7K sh	—	—	48,733
2023-09-15	ENVBEnveric Biosciences, Inc.P Purchase	Director	PPurchase	+1,000 sh	$2.14	+$2,140	1,000
2021-11-19	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−3,779 sh	$8.36	−$31.6K	429,783
2021-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−3,779 sh	$14.05	−$53.1K	433,562
2021-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−3,779 sh	$17.80	−$67.3K	437,341
2021-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−27K sh	$18.79	−$507K	439,719
2021-02-08	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+65K sh	—	—	466,680
2020-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−4,214 sh	$17.21	−$72.5K	401,680
2020-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−4,214 sh	$18.22	−$76.8K	405,894
2020-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−4,214 sh	$26.67	−$112K	410,108
2020-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−24.4K sh	$25.90	−$632K	412,920
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+65K sh	—	—	383,312
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+54K sh	—	—	437,312
2019-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−2,447 sh	$17.60	−$43.1K	318,312
2019-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−2,335 sh	$21.51	−$50.2K	320,759
2019-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−1,604 sh	$19.84	−$31.8K	323,094
2019-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−4,919 sh	$27.00	−$133K	323,671
2019-02-05	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+65K sh	—	—	281,340
2019-02-05	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+47.3K sh	—	—	328,590
2018-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−5,735 sh	$24.79	−$142K	216,340
2018-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−5,735 sh	$26.95	−$155K	222,075
2018-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−18.4K sh	$24.31	−$448K	227,810
2018-05-14	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+33.8K sh	—	—	246,234
2018-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−4,741 sh	$29.09	−$138K	211,619
2018-02-12	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+9,000 sh	—	—	216,360
2017-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−5,820 sh	$28.58	−$166K	207,360
2017-08-21	TBPHTheravance Biopharma, Inc.P Purchase	SVP, CHIEF BUSINESS OFFICER	PPurchase	+4,000 sh	$26.34	+$105K	213,180
2017-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−5,820 sh	$27.40	−$159K	209,180
2017-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−5,820 sh	$36.83	−$214K	215,000
2017-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−8,762 sh	$33.78	−$296K	219,118
2017-02-06	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+9,000 sh	—	—	227,880
2016-03-15	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+90K sh	—	—	217,178
2016-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, CHIEF BUSINESS OFFICER	FTax Payment	−10.8K sh	$15.65	−$169K	127,178
2015-02-05	TBPHTheravance Biopharma, Inc.A Award	SVP, CHIEF BUSINESS OFFICER	AAward	+130K sh	—	—	135,714
2014-01-23	INVAInnoviva, Inc.A Award	Sr. Vice President, Operations	AAward	+20K sh	—	—	20,000
2014-01-23	INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award	Sr. Vice President, Operations	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jun 34
PASQUALONE FRANK0001597334-26-000002
SEC(opens sec.gov)
Dec 304
PASQUALONE FRANK0001193125-25-337179
SEC(opens sec.gov)
Oct 114
PASQUALONE FRANK0001415889-24-025055
SEC(opens sec.gov)
Sep 194
PASQUALONE FRANK0001415889-23-013430
SEC(opens sec.gov)
Nov 234
PASQUALONE FRANK0001415889-21-005470
SEC(opens sec.gov)
Aug 244
PASQUALONE FRANK0001179110-21-008396
SEC(opens sec.gov)
May 244
PASQUALONE FRANK0001179110-21-005844
SEC(opens sec.gov)
Feb 234
PASQUALONE FRANK0001179110-21-002164
SEC(opens sec.gov)
Feb 104
PASQUALONE FRANK0001179110-21-001537
SEC(opens sec.gov)
Nov 244
PASQUALONE FRANK0001179110-20-011369
SEC(opens sec.gov)
Aug 244
PASQUALONE FRANK0001179110-20-009267
SEC(opens sec.gov)
May 224
PASQUALONE FRANK0001179110-20-006526
SEC(opens sec.gov)
Feb 244
PASQUALONE FRANK0001179110-20-002148
SEC(opens sec.gov)
Feb 54
PASQUALONE FRANK0001179110-20-001202
SEC(opens sec.gov)
Nov 224
PASQUALONE FRANK0001179110-19-012015
SEC(opens sec.gov)
Aug 224
PASQUALONE FRANK0001179110-19-009790
SEC(opens sec.gov)
May 224
PASQUALONE FRANK0001179110-19-006524
SEC(opens sec.gov)
Feb 224
PASQUALONE FRANK0001179110-19-002418
SEC(opens sec.gov)
Feb 74
PASQUALONE FRANK0001179110-19-001564
SEC(opens sec.gov)

Companies

Address

245 FIRST STREET, RIVERVIEW II 18TH FLOOR

CAMBRIDGE, MA, 02142